Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

NCT01454063 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Intraocular Lens Replacement

Interventions

DRUG: OMS302
DRUG: Placebo

Sponsor

Omeros Corporation